Dysbindin gene variability is associated with cognitive abnormalities in first-episode non-affective psychosis

References

• Andreasen, N. C. (1983). Scale for the Assessment of Negative Symptoms (SANS). Iowa City: University of Iowa.
   Google Scholar
• Andreasen, N. C. (1984). Scale for the Assessment of Positive Symptoms (SAPS). Iowa City: University of Iowa.
   Google Scholar
• Andreasen, N. C., Flaum, M., & Arndt, S. (1992). The Comprehensive Assessment of Symptoms and History (CASH): An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry, 49, 615–623. doi:10.1001/archpsyc.1992.01820080023004
   PubMed Web of Science ®Google Scholar
• Ayesa-Arriola, R., Pérez-Iglesias, R., Rodríguez-Sánchez, J. M., Pardo-García, G., Tabares-Seisdedos, R., Ayuso-Mateos, J. L., … Crespo-Facorro, B. (2013). Predictors of neurocognitive impairment at 3 years after a first episode non-affective psychosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 43, 23–28. doi:10.1016/j.pnpbp.2012.11.012
   PubMed Web of Science ®Google Scholar
• Bilder, R. M., Goldman, R. S., Robinson, D., Reiter, G., Bell, L., & Bates, J. A. (2000). Neuropsychology of first-episode schizophrenia: Initial characterization and clinical correlates. American Journal of Psychiatry, 157, 549–559. doi:10.1176/appi.ajp.157.4.549
   PubMed Web of Science ®Google Scholar
• Burdick, K. E., Goldberg, T. E., Funke, B., Bates, J. A., Lencz, T., Kucherlapati, R., & Malhotra, A. K. (2007). DTNBP1 genotype influences cognitive decline in schizophrenia. Schizophrenia Research, 89, 169–172. doi:10.1016/j.schres.2006.09.008
   PubMed Web of Science ®Google Scholar
• Burdick, K. E., Lencz, T., Funke, B., Finn, C. T., Szeszko, P. R., & Kane, J. M. (2006). Genetic variation in DTNBP1 influences general cognitive ability. Human Molecular Genetics, 15, 1563–1568. doi:10.1093/hmg/ddi481
   PubMed Web of Science ®Google Scholar
• Cannon, M., Caspi, A., Moffitt, T. E., Harrington, H., Taylor, A., Murray, R. M., & Poulton, R. (2002). Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: Results from a longitudinal birth cohort. Archives of General Psychiatry, 59, 449–456. doi:10.1001/archpsyc.59.5.449
   PubMed Web of Science ®Google Scholar
• Cannon, T. D., Zorrilla, L. E., Shtasel, D., Gur, R. E., Gur, R. C., & Marco, E. J. (1994). Neuropsychological functioning in siblings discordant for schizophrenia and healthy volunteers. Archives of General Psychiatry, 51, 651–661. doi:10.1001/archpsyc.1994.03950080063009
   PubMed Web of Science ®Google Scholar
• Donohoe, G., Morris, D. W., Clarke, S., McGhee, K. A., Schwaiger, S., Nangle, J.-M., … Corvin, A. (2007). Variance in neurocognitive performance is associated with dysbindin-1 in schizophrenia: A preliminary study. Neuropsychologia, 45, 454–458. doi:10.1016/j.neuropsychologia.2006.06.016
   PubMed Web of Science ®Google Scholar
• Egan, M. F., Hyde, T. M., Bonomo, J. B., Mattay, V. S., Bigelow, L. B., & Goldberg, T. E. (2001). Relative risk of neurological signs in siblings of patients with schizophrenia. American Journal of Psychiatry, 158, 1827–1834. doi:10.1176/appi.ajp.158.11.1827
   PubMed Web of Science ®Google Scholar
• Feng, Y. Q., Zhou, Z. Y., He, X., Wang, H., Guo, X. L., & Hao, C. J. (2008). Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia. Schizophrenia Research, 106, 218–228. doi:10.1016/j.schres.2008.07.018
   PubMed Web of Science ®Google Scholar
• Funke, B., Finn, C. T., Plocik, A. M., Lake, S., DeRosse, P., & Kane, J. M. (2004). Association of the DTNBP1 locus with schizophrenia in a U.S. population. American Journal of Human Genetics, 75, 891–898. doi:10.1086/425279S0002-9297(07)63795-1[pii]
   PubMed Web of Science ®Google Scholar
• González-Blanch, C., Crespo-Facorro, B., Álvarez-Jiménez, M., Rodríguez-Sánchez, J. M., Pelayo-Terán, J. M., Pérez-Iglesias, R., & Vázquez-Barquero, J. L. (2007). Cognitive dimensions in first-episode schizophrenia spectrum disorders. Journal of Psychiatric Research, 41, 968–977. doi:10.1016/j.jpsychires.2006.08.009
   PubMed Web of Science ®Google Scholar
• Green, M. F. (1996). What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153, 321–330.
   PubMed Web of Science ®Google Scholar
• Guo, A. Y., Sun, J., Riley, B. P., Thiselton, D. L., Kendler, K. S., & Zhao, Z. (2009). The dystrobrevin-binding protein 1 gene: Features and networks. Molecular Psychiatry, 14, 18–29. doi:10.1038/mp.2008.88
   PubMed Web of Science ®Google Scholar
• Hashimoto, R., Noguchi, H., Hori, H., Ohi, K., Yasuda, Y., Takeda, M., & Kunugi, H. (2009). Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects. Psychiatry and Clinical Neurosciences, 63, 550–556. doi:10.1111/j.1440-1819.2009.01985.x
   PubMed Web of Science ®Google Scholar
• Hattori, S., Murotani, T., Matsuzaki, S., Ishizuka, T., Kumamoto, N., Takeda, M., … Hashimoto, R. (2008). Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in DTNBP1, a susceptibility gene for schizophrenia. Biochemical and Biophysical Research Communications, 373, 298–302. doi:10.1016/j.bbrc.2008.06.016
   PubMed Web of Science ®Google Scholar
• Heinrichs, R. W., & Zakzanis, K. K. (1998). Neurocognitive deficit in schizophrenia: A quantitative review of the evidence. Neuropsychology, 12, 426–445. doi:10.1037/0894-4105.12.3.426
   PubMed Web of Science ®Google Scholar
• Jones, P., Rodgers, B., Murray, R., & Marmot, M. (1994). Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet, 344, 1398–1402. doi:10.1016/S0140-6736(94)90569-X
   PubMed Web of Science ®Google Scholar
• Keefe, R. S., Perkins, D. O., Gu, H., Zipursky, R. B., Christensen, B. K., & Lieberman, J. A. (2006). A longitudinal study of neurocognitive function in individuals at-risk for psychosis. Schizophrenia Research, 88, 26–35. doi:10.1016/j.schres.2006.06.041
   PubMed Web of Science ®Google Scholar
• Kirov, G., Ivanov, D., Williams, N. M., Preece, A., Nikolov, I., & Milev, R. (2004). Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biological Psychiatry, 55, 971–975. doi:10.1016/j.biopsych.2004.01.025S0006322304001118[pii]
   PubMed Web of Science ®Google Scholar
• Kobayashi, K., Umeda-Yano, S., Yamamori, H., Takeda, M., Suzuki, H., & Hashimoto, R. (2011). Correlated alterations in serotonergic and dopaminergic modulations at the hippocampal mossy fiber synapse in mice lacking dysbindin. PLoS ONE, 6, e18113. doi:10.1371/journal.pone.0018113
   Web of Science ®Google Scholar
• McIntosh, A. M., Harrison, L. K., Forrester, K., Lawrie, S. M., & Johnstone, E. C. (2005). Neuropsychological impairments in people with schizophrenia or bipolar disorder and their unaffected relatives. British Journal of Psychiatry, 186, 378–385. doi:10.1192/bjp.186.5.378
   PubMed Web of Science ®Google Scholar
• Morris, D. W., Murphy, K., Kenny, N., Purcell, S. M., McGhee, K. A., Schwaiger, S., … Corvin, A. P. (2008). Dysbindin (DTNBP1) and the biogenesis of lysosome-related organelles complex 1 (BLOC-1): Main and epistatic gene effects are potential contributors to schizophrenia susceptibility. Biological Psychiatry, 63, 24–31. doi:10.1016/j.biopsych.2006.12.025
   PubMed Web of Science ®Google Scholar
• Papaleo, F., & Weinberger, D. R. (2011). Dysbindin and schizophrenia: It's dopamine and glutamate all over again. Biological Psychiatry, 69, 2–4. doi:10.1016/j.biopsych.2010.10.028
   PubMed Web of Science ®Google Scholar
• Saggu, S., Cannon, T. D., Jentsch, J. D., & Lavin, A. (2013). Potential molecular mechanisms for decreased synaptic glutamate release in dysbindin-1 mutant mice. Schizophrenia Research, 146, 254–263. doi:10.1016/j.schres.2013.01.037
   PubMed Web of Science ®Google Scholar
• Saykin, A. J., Shtasel, D. L., Gur, R. E., Kester, D. B., Mozley, L. H., & Stafiniak, P. (1994). Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia. Archives of General Psychiatry, 51, 124–131. doi:10.1001/archpsyc.1994.03950020048005
   PubMed Web of Science ®Google Scholar
• Schwab, S. G., Knapp, M., Mondabon, S., Hallmayer, J., Borrmann-Hassenbach, M., Albus, M., … Wildenauer, D. B. (2003). Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. American Journal of Human Genetics, 72, 185–190. doi:10.1086/345463
   PubMed Web of Science ®Google Scholar
• Shao, L., Shuai, Y., Wang, J., Feng, S., Lu, B., & Li, Z. (2011). Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila. Proceedings of the National Academy Sciences of the United States of America, 108, 18831–18836. doi:10.1073/pnas.1114569108
   PubMed Web of Science ®Google Scholar
• Straub, R. E., Jiang, Y., MacLean, C. J., Ma, Y., Webb, B. T., & Myakishev, M. V. (2002). Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. American Journal of Human Genetics, 71, 337–348. doi:10.1086/341750
   PubMed Web of Science ®Google Scholar
• Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., & Smith, R. J. (2004). Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. Journal of Clinical Investigation, 113, 1353–1363. doi:10.1172/JCI20425
   PubMed Web of Science ®Google Scholar
• Tan, H. Y. (2009). Cognitive dysfunction in schizophrenia: A perspective from the clinic to genetic brain mechanisms. Annals of the Academy of Medicine, Singapore, 38, 420–425.
   PubMed Web of Science ®Google Scholar
• Tang, J., LeGros, R. P., Louneva, N., Yeh, L., Cohen, J. W., Hahn, C.-G., … Talbot, K. (2009). Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Human Molecular Genetics, 18, 3851–3863. doi:10.1093/hmg/ddp329
   PubMed Web of Science ®Google Scholar
• Toulopoulou, T., Picchioni, M., Rijsdijk, F., Hua-Hall, M., Ettinger, U., Sham, P., & Murray, R. (2007). Substantial genetic overlap between neurocognition and schizophrenia: Genetic modeling in twin samples. Archives of General Psychiatry, 64, 1348–1355. doi:10.1001/archpsyc.64.12.1348
   PubMed Web of Science ®Google Scholar
• Van Den Bogaert, A., Schumacher, J., Schulze, T. G., Otte, A. C., Ohlraun, S., Kovalenko, S., … Cichon, S. (2003). The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. American Journal of Human Genetics, 73, 1438–1443. doi:10.1086/379928
   PubMed Web of Science ®Google Scholar
• Weickert, C. S., Rothmond, D. A., Hyde, T. M., Kleinman, J. E., & Straub, R. E. (2008). Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophrenia Research, 98, 105–110. doi:10.1016/j.schres.2007.05.041
   PubMed Web of Science ®Google Scholar
• Weickert, C. S., Straub, R. E., McClintock, B. W., Matsumoto, M., Hashimoto, R., & Hyde, T. M. (2004). Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Archives of General Psychiatry, 61, 544–555. doi:10.1001/archpsyc.61.6.54461/6/544[pii]
   PubMed Web of Science ®Google Scholar
• Williams, N. M., O’Donovan, M. C., & Owen, M. J. (2005). Is the dysbindin gene (DTNBP1) a susceptibility gene for schizophrenia? Schizophrenia Bulletin, 31, 800–805. doi:10.1093/schbul/sbi061
   PubMed Web of Science ®Google Scholar
• Zhao, J. H., Lissarrague, S., Essioux, L., & Sham, P. C. (2002). GENECOUNTING: Haplotype analysis with missing genotypes. Bioinformatics, 18, 1694–1695. doi:10.1093/bioinformatics/18.12.1694
   PubMed Web of Science ®Google Scholar
• Zinkstok, J. R., de Wilde, O., van Amelsvoort, T. A., Tanck, M. W., Baas, F., & Linszen, D. H. (2007). Association between the DTNBP1 gene and intelligence: A case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behavioral and Brain Functions, 3, 19. doi:10.1186/1744-9081-3-19
   PubMed Web of Science ®Google Scholar